Intraoperative radiotherapy for brain metastases: first-stage results of a single-arm, open-label, phase 2 trial

被引:0
|
作者
Douglas Guedes de Castro
Paulo Issamu Sanematsu
Antônio Cassio Assis Pellizzon
Sérgio Hideki Suzuki
Ricardo Cesar Fogaroli
José Eduardo Souza Dias
Guilherme Rocha Melo Gondim
Daniel Alvarez Estrada
Maria Letícia Gobo Silva
Marcio Saquy Rassi
Michael Jenwei Chen
Richard Giacomelli
Henderson Ramos
Elson Santos Neto
Carolina Humeres Abrahão
Tharcisio Machado Coelho
Liao Shin Yu
Cassio de Queiroz Tannous
Vinicius Fernando Calsavara
Frank Anton Giordano
Jean Gonçalves de Oliveira
机构
[1] A.C. Camargo Cancer Center,Department of Radiation Oncology
[2] A.C. Camargo Cancer Center,Department of Neurosurgery
[3] A.C. Camargo Cancer Center,Department of Imaging
[4] Cedars-Sinai Medical Center,Samuel Oschin Comprehensive Cancer Institute
[5] Heidelberg University,Department of Radiation Oncology, DKFZ
[6] Santa Casa de São Paulo School of Medical Sciences,Hector Cancer Institute, Medical Faculty Mannheim
来源
Journal of Neuro-Oncology | 2023年 / 162卷
关键词
Brain metastases; Neurosurgery; Radiotherapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:211 / 215
页数:4
相关论文
共 50 条
  • [11] Sunitinib in Refractory Adrenocortical Carcinoma: A Phase II, Single-Arm, Open-Label Trial
    Kroiss, Matthias
    Quinkler, Marcus
    Johanssen, Sarah
    van Erp, Nielka P.
    Lankheet, Nienke
    Poellinger, Alexander
    Laubner, Katharina
    Strasburger, Christian J.
    Hahner, Stefanie
    Mueller, Hans-Helge
    Allolio, Bruno
    Fassnacht, Martin
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (10): : 3495 - 3503
  • [12] Pulmonary resectable metastases of osteosarcoma with apatinib and chemotherapy (PROACH): An open-label, single-arm phase II clinical trial
    Bao, Q.
    Zhang, Z.
    Wen, J.
    Wan, R.
    Yang, X.
    Chen, X.
    Shen, Y.
    Zhang, W.
    ANNALS OF ONCOLOGY, 2023, 34 : S1712 - S1712
  • [13] Nintedanib for patients with lymphangioleiomyomatosis: a phase 2, open-label, single-arm study
    Harari, Sergio
    Elia, Davide
    Caminati, Antonella
    Geginat, Jens
    Luisi, Francesca
    Pelosi, Giuseppe
    Specchia, Claudia
    Torre, Olga
    Trevisan, Roberta
    Vasco, Chiara
    Zompatori, Maurizio
    Cassandro, Roberto
    LANCET RESPIRATORY MEDICINE, 2024, 12 (12): : 967 - 974
  • [14] An open-label, single-arm, phase II trial of buparlisib in patients with melanoma brain metastases not eligible for surgery or radiosurgery-the BUMPER study
    Amaral, Teresa
    Niessner, Heike
    Sinnberg, Tobias
    Thomas, Ioannis
    Meiwes, Andreas
    Garbe, Claus
    Garzarolli, Marlene
    Rauschenberg, Ricarda
    Eigentler, Thomas
    Meier, Friedegund
    NEURO-ONCOLOGY ADVANCES, 2020, 2 (01)
  • [15] Mocetinostat for relapsed classical Hodgkin's lymphoma: an open-label, single-arm, phase 2 trial
    Younes, Anas
    Oki, Yasuhiro
    Bociek, R. Gregory
    Kuruvilla, John
    Fanale, Michelle
    Neelapu, Sattva
    Copeland, Amanda
    Buglio, Daniela
    Galal, Ahmed
    Besterman, Jeffrey
    Li, Zuomei
    Drouin, Michel
    Patterson, Tracy
    Ward, M. Renee
    Paulus, Jessica K.
    Ji, Yuan
    Medeiros, L. Jeffrey
    Martell, Robert E.
    LANCET ONCOLOGY, 2011, 12 (13): : 1222 - 1228
  • [16] Publisher Correction: Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosis
    Priscilla K. Brastianos
    Eudocia Quant Lee
    Justine V. Cohen
    Sara M. Tolaney
    Nancy U. Lin
    Nancy Wang
    Ugonma Chukwueke
    Michael D. White
    Naema Nayyar
    Albert Kim
    Christopher Alvarez-Breckenridge
    Ian Krop
    Maura Keeley Mahar
    Mia S. Bertalan
    Brian Shaw
    Joana L. Mora
    Nathaniel Goss
    Megha Subramanian
    Lakshmi Nayak
    Jorg Dietrich
    Deborah A. Forst
    Brian V. Nahed
    Tracy T. Batchelor
    Helen A. Shih
    Elizabeth R. Gerstner
    Beverly Moy
    Donald Lawrence
    Anita Giobbie-Hurder
    Scott L. Carter
    Kevin Oh
    Daniel P. Cahill
    Ryan J. Sullivan
    Nature Medicine, 2020, 26 : 1309 - 1309
  • [17] Apremilast for Discoid Lupus Erythematosus: Results of a Phase 2, Open-Label, Single-Arm, Pilot Study
    De Souza, Aieska
    Strober, Bruce E.
    Merola, Joseph F.
    Oliver, Stephen
    Franks, Andrew G., Jr.
    JOURNAL OF DRUGS IN DERMATOLOGY, 2012, 11 (10) : 1224 - 1226
  • [18] Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial
    Migden, Michael R.
    Khushalani, Nikhil I.
    Chang, Anne Lynn S.
    Lewis, Karl D.
    Schmults, Chrysalyne D.
    Hernandez-Aya, Leonel
    Meier, Friedegund
    Schadendorf, Dirk
    Guminski, Alexander
    Hauschild, Axel
    Wong, Deborah J.
    Daniels, Gregory A.
    Berking, Carola
    Jankovic, Vladimir
    Stankevich, Elizabeth
    Booth, Jocelyn
    Li, Siyu
    Weinreich, David M.
    Yancopoulos, George D.
    Lowy, Israel
    Fury, Matthew G.
    Rischin, Danny
    LANCET ONCOLOGY, 2020, 21 (02): : 294 - 305
  • [19] Brain radiotherapy combined with camrelizumab and platinum-based chemotherapy as first-line treatment for advanced NSCLC with brain metastases: A multicenter, open-label, single-arm, phase II study
    Fan, Y.
    Xu, Y.
    Huang, Z.
    Xu, Y.
    Sheng, L.
    Li, H.
    Lu, H.
    Chen, K.
    Yu, S.
    Gong, L.
    Han, N.
    Xu, X.
    Qin, J.
    Xie, F.
    Hong, W.
    Huang, D.
    Chen, J.
    ANNALS OF ONCOLOGY, 2023, 34
  • [20] Toripalimab plus intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma: an open-label single-arm, phase II trial
    Hua, Yijun
    You, Rui
    Wang, Zhiqiang
    Huang, Peiyu
    Lin, Mei
    Ouyang, Yanfeng
    Xie, Yulong
    Zou, Xiong
    Liu, Youping
    Duan, Chongyang
    Liu, Yonglong
    Gu, Chenmei
    Liu, Rongzeng
    Yang, Qi
    Jiang, Rou
    Zhang, Mengxia
    Ding, Xi
    Chen, Siyuan
    Lin, Chao
    Sun, Rui
    Chen, Mingyuan
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (11)